title: Effect of practice integration between urologists and radiation oncologists on prostate cancer treatment patterns.
abstract: OBJECTIVE
  National attention has focused on whether urology-radiation oncology practice integration, known as integrated prostate cancer centers, contributes to the use of intensity modulated radiation therapy, a common and expensive prostate cancer treatment.
  
  
  METHODS
  We examined prostate cancer treatment patterns before and after conversion of a urology practice to an integrated prostate cancer center in July 2006. Using the SEER (Statistics, Epidemiology and End Results)-Medicare database, we identified patients 65 years old or older in 1 statewide registry diagnosed with nonmetastatic prostate cancer between 2004 and 2007. We classified patients into 3 groups, including 1--those seen by integrated prostate cancer center physicians (exposure group), 2--those living in the same hospital referral region who were not seen by integrated prostate cancer center physicians (hospital referral region control group) and 3--those living elsewhere in the state (state control group). We compared changes in treatment among the 3 groups, adjusting for patient, clinical and socioeconomic factors.
  
  
  RESULTS
  Compared with the 8.1 ppt increase in adjusted intensity modulated radiation therapy use in the state control group, the use of this therapy increased 20.3 ppts (95% CI 13.4, 27.1) in the integrated prostate cancer center group and 19.2 ppts (95% CI 9.6, 28.9) in the hospital referral region control group. Androgen deprivation therapy, for which Medicare reimbursement decreased sharply, similarly decreased in integrated prostate cancer center and hospital referral region controls. Prostatectomy decreased significantly in the integrated prostate cancer center group.
  
  
  CONCLUSIONS
  Coincident with the conversion of a urology group practice to an integrated prostate cancer center, we observed an increase in intensity modulated radiation therapy and a decrease in androgen deprivation therapy in patients seen by integrated prostate cancer center physicians and those seen in the surrounding health care market that were not observed in the remainder of the state.
authors: Department of Radiation Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA. bekelman@uphs.upenn.edu
authors: Justin E
authors: JE
authors: Bekelman
authors: Gita
authors: G
authors: Suneja
authors: Thomas
authors: T
authors: Guzzo
authors: Craig Evan
authors: CE
authors: Pollack
authors: Katrina
authors: K
authors: Armstrong
authors: Andrew J
authors: AJ
authors: Epstein
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D001707:Biopsy, Needle; D002173:Cancer Care Facilities / Q000458:organization & administration; D016208:Databases, Factual; D019033:Delivery of Health Care, Integrated / Q000458:organization & administration; D018572:Disease-Free Survival; D006123:Group Practice / Q000458:organization & administration*; D006801:Humans; D007400:Interprofessional Relations; D008297:Male; D008495:Medical Oncology / Q000458:organization & administration*; D008875:Middle Aged; D010818:Practice Patterns, Physicians'; D011379:Prognosis; D017430:Prostate-Specific Antigen / Q000097:blood*; D011471:Prostatic Neoplasms / Q000401:mortality / Q000473:pathology / Q000532:radiotherapy* / Q000601:surgery*; D011787:Quality of Health Care; D018787:Radiation Oncology / Q000458:organization & administration*; D050397:Radiotherapy, Intensity-Modulated / Q000379:methods; D018570:Risk Assessment; D018426:SEER Program; D016019:Survival Analysis; D016896:Treatment Outcome; D014572:Urology
chemical_list: D017430:Prostate-Specific Antigen
references: Health Serv Res. 2009 Feb;44(1):288-302
references: 18793213
references: Eur Urol. 2010 Mar;57(3):453-8
references: 19931979
references: J Natl Cancer Inst. 2011 Jan 19;103(2):117-28
references: 21228314
references: J Natl Cancer Inst. 2008 May 7;100(9):630-41
references: 18445825
references: J Urol. 2011 Sep;186(3):860-4
references: 21788052
references: N Y Times Web. 2006 Dec 1;:A1, C7
references: 17167872
references: Health Aff (Millwood). 2012 Apr;31(4):750-9
references: 22492892
references: Med Care. 1998 Jan;36(1):8-27
references: 9431328
references: JAMA. 2011 Nov 9;306(18):2028-30
references: 22068998
references: N Engl J Med. 2005 Mar 3;352(9):857-9
references: 15745974
references: Science. 1973 Dec 14;182(4117):1102-8
references: 4750608
references: Int J Radiat Oncol Biol Phys. 2010 Apr;76(5):1285-8
references: 20338470
references: Int J Radiat Oncol Biol Phys. 2012 May 1;83(1):8-15
references: 22079721
references: N Engl J Med. 1992 Nov 19;327(21):1497-501
references: 1406881
references: J Clin Oncol. 2011 Apr 20;29(12):1517-24
references: 21402604
references: Health Aff (Millwood). 2006 Sep-Oct;25(5):w337-43
references: 16868008
references: N Engl J Med. 2010 Nov 4;363(19):1822-32
references: 21047226